Models of care and associated targeted implementation strategies for cancer survivorship support in Europe: a scoping review protocol
- Author(s)
- Prue, G; Czamanski-Cohen, J; Kassianos, AP; Pilleron, S; Ladas, A; Akcakaya Can, A; Roldán-Jiménez, C; Degi, CL; Işcan, G; Arslan, S; de Boer, AGEM; Celebic, A; Doñate-Martínez, A; Alhambra-Borrás, T; Mitrevski, B; Marzorati, C; Pravettoni, G; Grasso, R; Nazik, E; Pawlowska, E; Mucalo, I; Browne, JP; Tripkovic, K; Vojvodic, K; Karekla, M; Moschofidou, M; Bayram, SB; Brandão, T; Arndt, V; Jaswal, P; Semerci, R; Bozkul, G; Sahin, E; Toygar, I; Frountzas, M; Martins, RM; Jefford, M; Keane, D; Hegarty, J;
- Details
- Publication Year 2025-02-16,Volume 15,Issue #2,Page e085456
- Journal Title
- BMJ Open
- Publication Type
- Protocol
- Abstract
- INTRODUCTION: Cancer and its treatments can lead to a wide range of side-effects that can persist long after treatments have ended. Across Europe, survivorship care is traditionally hospital-based specialist-led follow-up, leading to gaps in supportive care. Improved screening, diagnosis and treatment increase survival rates. With more individuals living with, through and beyond cancer, the predominance of the hospital-based specialist model is unsustainable, costly and resource-intensive. An understanding of what alternative Models of Care are available and the barriers and facilitators to their implementation is a first step towards enhancing supportive care across the cancer journey. The aim of this scoping review is to source and synthesise information from studies evaluating patient-oriented models of cancer survivorship supportive care for adults in Europe. METHODS AND ANALYSIS: The scoping review will be reported in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses-Scoping Review Extension guidelines and will be guided by a six-stage methodological framework. A search strategy has been developed according to the Population, Concept and Context structure and will be applied to seven databases. A targeted search of grey literature will be completed. All identified records will be screened using predefined eligibility criteria by at least two researchers and undergo full-text review for inclusion. Data pertaining to the conceptualisation, evaluation and implementation of sourced Models of Care will be extracted. ETHICS AND DISSEMINATION: As there is no primary data, ethical approval is not required. This review will be conducted as part of the EU COST Action CA21152-Implementation Network Europe for Cancer Survivorship Care. The protocol and subsequent scoping review will be published in a peer-reviewed journal. The Action involves representatives from most countries across Europe which will assist with the dissemination of the work to key stakeholders.
- Keywords
- Humans; Europe; *Cancer Survivors; *Neoplasms/therapy; Research Design; Survivorship; Delivery of Health Care, Integrated; Health Services; Health policy; International health services; Patient-Centered Care; Review
- Department(s)
- Medical Oncology; Australian Cancer Survivorship Centre
- Publisher's Version
- https://doi.org/10.1136/bmjopen-2024-085456
- Open Access at Publisher's Site
https://doi.org/10.1136/bmjopen-2024-085456
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2025-03-21 04:37:03
Last Modified: 2025-03-21 04:37:45